Listed equity
Ajanta Pharma
अजंता फर्मा · અજંતા ફાર્મા
₹3313.00▼₹5.05(-0.15%)
EOD close · 3 Jul 2026
mid rallydistribution -33
The price is rising, but delivery data shows distribution underneath. Rallies without conviction can fade — watch the delivery numbers.
52W low ₹2335.0052W high ₹3505.55
Now at 84% of its 52-week range
Long-term returns
1Y
+27.0%
3Y
+126.8%
5Y
+135.8%
10Y
+228.3%
Phase indicator
mid rally-5.5% from 52w high
Above 50- and 200-day MAs with +19.4% over 3 months — established uptrend.
1M
+13.9%
3M
+19.4%
1Y
+27.0%
Delivery conviction
distributionscore -33
Delivery vs 20-day avg0.18x
Lifetime story
Ajanta Pharma is up 176123.4% from its lifetime low of ₹1.88 on 1 Apr 2003. ₹10,000 invested then would be worth ₹1,76,22,340 today (37.9% CAGR over 23.3 years). Lifetime high of ₹3505.55 was set on 1 Jul 2026 (currently -5.5% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
11% cheaper than industry(Industry P/E 49.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM) | 44.05 | 39.49 |
| P/B | 9.88 | 9.22 |
| Price / Cash flow | 37.38 | 33.93 |
| Dividend yield | 0.84% | 0.84% |
| Book value / share | 338.11 ₹ | 362.42 ₹ |
| EPS (TTM) | 75.80 ₹ | 84.54 ₹ |
Market cap
₹41.7K Cr
52W high
₹3505.55
1 Jul 2026
52W low
₹2335.00
30 Sept 2025
Returns ladder
1W
+5.1%
1M
+13.9%
3M
+19.4%
6M
+13.7%
YTD
+20.5%
1Y
+27.0%
3Y
+126.8%
5Y
+135.8%
10Y
+228.3%
Since listing
+10000.0%